Trobix Bio is a company that develops and commercializes antibacterial products.
Trobix Bio has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in March 2023.
Trobix Bio's investors include Chartered Opus.
Trobix Bio is headquartered in Netanya, Israel.
Trobix Bio is a company that develops and commercializes antibacterial products.
Trobix Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trobix Bio — Funding & Investors." VCBacked, March 30, 2023, https://www.vcbacked.co/company/trobix-bio. Accessed September 14, 2026.
VCBacked. (2023). Trobix Bio — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/trobix-bio
{{cite web |title=Trobix Bio — Funding & Investors |url=https://www.vcbacked.co/company/trobix-bio |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated